National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No. 2) (No. PB 17 of 2012)

Link to law: https://www.comlaw.gov.au/Details/F2012L00727

Subscribe to a Global-Regulation Premium Membership Today!

Key Benefits:

Subscribe Now
 
National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No.2)
Instrument number PB 17 of 2012
National Health Act 1953
I, ADRIANA PLATONA, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the
Minister for Health, make this determination under subsection 85AB(1) of the National Health Act 1953.
Dated                  27         March   2012
 
 
 
 
 
 
 
 
 
ADRIANA PLATONA
 
Assistant Secretary
Pharmaceutical Evaluation Branch
Pharmaceutical Benefits Division
Department of Health and Ageing
 
 
Part 1         Preliminary
1              Name of Determination
         (1)   This Determination is the National Health (Listed drugs on F1 or F2) Amendment Determination 2012 (No.2).
         (2)   This Determination may also be cited as PB 17 of 2012.
2              Commencement
                This Determination commences on 1 April 2012.
3              Amendment of National Health (Listed drugs on F1 or F2) Determination 2010
                Schedule 1 amends the National Health (Listed drugs on F1 or F2) Determination 2010 (PB 93 of 2010).
Schedule 1             Amendments
 
(Section 3)
 
 
[1]     Schedule 1, after item dealing with Anakinra
 
Omit
 
Anastrozole 
 
 
[2]     Schedule 1, after item dealing with Atomoxetine
 
Omit
 
Atorvastatin 
 
[3]     Schedule 1, after item dealing with Lenograstim
 
Omit
 
Letrozole 
 
[4]     Schedule 1, after item dealing with Mupirocin
 
Omit
 
Mycophenolic acid 
 
[5]     Schedule 1, after item dealing with Ofloxacin
 
Omit
 
Olanzapine 
 
[6]     Schedule 1, after item dealing with Pyrimethamine
 
Omit
 
Quetiapine 
 
[7]     Schedule 1, after item dealing with Rifampicin
 
Insert
 
Rilpivirine 
 
 
[8]     Schedule 1, after item dealing with Rosiglitazone
 
Omit
 
Rosuvastatin 
 
[9]     Schedule 1, after item dealing with Sunitinib
 
Insert
 
Tadalafil 
 
 
[10]   Schedule 1, after item dealing with Varenicline
 
Omit
 
Venlafaxine 
 
 
[11]   Schedule 2, after item dealing with Ampicillin
 
Insert
 
Anastrozole 
 
 
[12]   Schedule 2, after item dealing with Atenolol
 
Insert
 
Atorvastatin
 
[13]   Schedule 2, after item dealing with Lercanidipine
 
Insert
 
Letrozole
 
[14]   Schedule 2, after item dealing with Morphine
 
Insert
 
Mycophenolic acid
 
 
 
[15]   Schedule 2, after item dealing with Oestradiol
 
Insert
 
Olanzapine
 
[16]   Schedule 2, after item dealing with Prochlorperazine
 
Insert
 
Quetiapine
 
[17]   Schedule 2, after item dealing with Risperidone
 
Insert
 
Rosuvastatin
 
[18]   Schedule 2, after item dealing with Vancomycin
 
Insert
 
Venlafaxine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note
1.       All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003. See http://www.frli.gov.au.